➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
AstraZeneca
Harvard Business School
Boehringer Ingelheim
McKinsey

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Tideglusib


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Tideglusib?

Tideglusib is an investigational drug.

There have been 6 clinical trials for Tideglusib. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2020.

The most common disease conditions in clinical trials are Myotonic Dystrophy, Alzheimer Disease, and Autistic Disorder. The leading clinical trial sponsors are Noscira SA, AMO Pharma Limited, and Holland Bloorview Kids Rehabilitation Hospital.

There are seventy-six US patents protecting this investigational drug and five hundred and sixty-four international patents.

Recent Clinical Trials for Tideglusib
TitleSponsorPhase
Efficacy and Safety of Tideglusib in Congenital Myotonic DystrophyAMO Pharma LimitedPhase 2/Phase 3
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum DisordersHolland Bloorview Kids Rehabilitation HospitalPhase 2
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum DisordersMcMaster UniversityPhase 2

See all Tideglusib clinical trials

Clinical Trial Summary for Tideglusib

Top disease conditions for Tideglusib
Top clinical trial sponsors for Tideglusib

See all Tideglusib clinical trials

US Patents for Tideglusib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tideglusib   Get Started Free Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III Frequency Therapeutics, Inc. (Woburn, MA)   Get Started Free
Tideglusib   Get Started Free .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof Quadriga Biosciences, Inc. (Los Altos, CA)   Get Started Free
Tideglusib   Get Started Free Compositions and methods for treating cancers CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA)   Get Started Free
Tideglusib   Get Started Free Imidazopyridazine compounds Pfizer Inc. (New York, NY)   Get Started Free
Tideglusib   Get Started Free Pyrazolopyrimidine compounds Pfizer Inc. (New York, NY)   Get Started Free
Tideglusib   Get Started Free Reprogramming fibroblasts into cardiomyocytes THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE (San Francisco, CA)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tideglusib

Drugname Country Document Number Estimated Expiration Related US Patent
Tideglusib Argentina AR105592 2035-08-03   Get Started Free
Tideglusib Australia AU2016302243 2035-08-03   Get Started Free
Tideglusib Canada CA2994404 2035-08-03   Get Started Free
Tideglusib China CN108026026 2035-08-03   Get Started Free
Tideglusib European Patent Office EP3331851 2035-08-03   Get Started Free
Tideglusib Hong Kong HK1247608 2035-08-03   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
Express Scripts
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.